Cronos Group Inc. reports developments for a global cannabis and cannabinoid company focused on consumer goods, cannabis research, technology and product development. Its brand portfolio includes Spinach®, PEACE NATURALS®, LIT® and Lord Jones®, with news often centered on product innovation across Canadian cannabis formats such as pre-rolls and vapes.
Recurring Cronos updates also cover operating and financial results, earnings conference calls, annual shareholder meetings, proxy and governance matters, capital-structure disclosures and public-company presentations. The company’s disclosures connect brand launches and R&D-driven product development with the financial and governance reporting of a Nasdaq- and TSX-listed cannabis issuer.
Almonty Industries (NASDAQ: ALM) appointed two independent directors effective immediately and announced its intention to pursue a secondary Korea Exchange listing. Dr. Eugene Bae and Jim Rudyk joined the Board. David Hanick and Andrew Frazer will step down on December 31, 2026, leaving seven directors, five independent. Hanick will remain General Counsel, and Frazer will remain an executive consultant.
The proposed KRX listing would complement Nasdaq trading, which will continue under ALM. Completion depends on KRX and Korean regulatory approvals, market conditions and securities-law compliance; no completion timeline is assured. Almonty expects to appoint a lead banker in Korea shortly. Management also described Sangdong's ramp toward full Phase I capacity, expansion into level 2 and advancement of a tungsten oxide plant.
Cronos Group (NASDAQ: CRON; TSX: CRON) reported third-quarter 2026 net revenue of $63.45 million, setting a quarterly record.
Revenue rose 75% year over year, or 73% organically at constant currency. Gross profit increased 76% to $32.283 million, with gross margin reaching 50.9%. Adjusted EBITDA, a non-GAAP measure of earnings before interest, taxes, depreciation and amortization, rose 201% to $17.076 million. Net income fell 37% to $17.826 million, reflecting lower other income, higher operating expenses and an income tax provision versus a prior-year benefit.
Israel revenue grew 33%, while international revenue excluding Israel increased 614%. Cronos repurchased 3.2 million shares for $9.4 million during the quarter and completed its CanAdelaar acquisition on October 15, 2026. Cash, restricted cash and interest-bearing deposits totaled $840.629 million at September 30.
Cronos Group (CRON) completed its acquisition of all outstanding CanAdelaar shares for a base purchase price of €57.5 million. The price is subject to closing and post-closing adjustments, with additional cash payments equal to 0.5x CanAdelaar’s Normalized EBITDA, as contractually defined, for each of 2026 and 2027.
The acquisition establishes a Netherlands operating platform within the Wietexperiment adult-use cannabis pilot. Cronos plans to introduce its genetics and products through the acquired business. CanAdelaar’s annualized first-half 2026 revenue was €41.6 million and adjusted EBITDA, a non-GAAP earnings measure, was €20.1 million; these unaudited annualized figures are neither full-year results nor forecasts. Increased competition primarily drove the earnings decline from €24.2 million in the twelve months ended September 30, 2025. Cronos’ subsidiary waived all contractual closing conditions; a seller provided limited regulatory and environmental indemnities.
Cronos Group (CRON) is bringing back its limited-edition Spinach green apple gummies and vape products for the fall season.
The Caramel Green Apple flavor returns for the third consecutive year and, for the first time, is available exclusively in the SOURZ by Spinach Fully Blasted 10-pack, containing 10 gummies with 10mg THC each. The Sweet Green Apple 1g vape, first launched in 2025, is also returning. Both seasonal products are available now across Canada.
Cronos Group (CRON) will hold its 2026 third quarter earnings conference call on November 5, 2026, at 8:30 a.m. ET. Senior management will discuss financial results and take questions from the investment community after prepared remarks. The webcast will be archived for replay on the company’s website.
Cronos Group (CRON) is hosting its first Investor Day on September 24, 2026, at its Cronos Growing Company location in Kingsville.
The webcast begins at 12:00 p.m. ET. Presentation materials are available on the company’s Investor Relations website under Events & Presentations. A recording will be archived there for replay after the event and available for 12 months.
Cronos (CRON) will host its first Investor Day on Thursday, September 24, 2026, at its Cronos GrowCo greenhouse facility in Kingsville, Ontario.
The event, led by the Cronos leadership team, includes a fireside chat with CEO Mike Gorenstein and Cronos GrowCo CEO Bert Mucci, executive presentations, and an in-person tour of the 1.3 million square foot greenhouse. A live webcast will begin at 12:00 p.m. ET, with registration available online and a replay archived on the company’s website for 12 months.
Cronos (CRON) announced an expansion of its Spinach® brand edibles and vape portfolios with new SOURZ by Spinach® Blue Raspberry Lemonade Fully Blasted gummies and two new vape cartridge flavors.
The Blue Raspberry Lemonade Fully Blasted multipack is the brand’s first gummy infused with 100% live resin and is sold exclusively in the SOURZ by Spinach® Fully Blasted 10-pack, described as Canada’s No. 1 edible multipack by June 2026 retail data. Cronos is also launching Spinach® Strawberry Banana 1.2g indica vape and Spinach® Sweet Citrus Punch 1g sativa liquid diamonds vape. The new products are available now in Ontario, with wider national availability expected later in the fall of 2026.
Summary not available.
Cronos (NASDAQ: CRON, TSX: CRON) is expanding its SOURZ by Spinach® Fully Blasted edible multipack lineup in Canada, adding liquid diamond-infused gummies featuring rare cannabinoid formulations and a new limited-time Orange Cream flavor for summer. According to Cronos, SOURZ by Spinach® Fully Blasted multipacks were the #1 edible multipack in Canada, holding a 31.7% share of all 10x10 pack sales in May 2026, while the Spinach® brand led national edibles with 20.8% market share in the same month. New 10-pack gummies include Orange Cream (THC), Strawberry Watermelon 1:1 CBG|THC, Peach Passionfruit 1:1 CBN|THC, and Mango Lime 1:1 CBC|THC, now available in Alberta, Manitoba, Ontario, and Saskatchewan.